Hydroxyurea dermopathy
Hydroxyurea Dermopathy
Hydroxyurea Dermopathy (pronunciation: hy·drox·y·u·re·a der·mop·a·thy) is a skin condition that is associated with the long-term use of Hydroxyurea, a medication used in the treatment of certain types of cancer and sickle cell disease.
Etymology
The term "Hydroxyurea Dermopathy" is derived from the name of the drug 'Hydroxyurea' and the Greek word 'derma' meaning skin, and 'pathy' meaning disease.
Definition
Hydroxyurea Dermopathy is characterized by hyperpigmentation, scaling, and atrophy of the skin. It is a rare side effect of the drug Hydroxyurea, which is used to treat conditions such as polycythemia vera, essential thrombocythemia, and chronic myeloid leukemia.
Symptoms
The symptoms of Hydroxyurea Dermopathy include:
- Hyperpigmentation: Darkening of the skin
- Scaling: Flaking or peeling of the skin
- Atrophy: Thinning of the skin
Treatment
Treatment for Hydroxyurea Dermopathy primarily involves discontinuing the use of Hydroxyurea. In some cases, topical treatments may be used to manage symptoms. It is important to consult with a dermatologist or oncologist for appropriate treatment options.
Related Terms
- Dermatology: The branch of medicine dealing with the skin and its diseases
- Hyperpigmentation: Darkening of an area of skin caused by increased melanin
- Atrophy: Waste away, typically due to the degeneration of cells
- Scaling (skin): The loss of the outer layer of the epidermis in large, scale-like flakes
External links
- Medical encyclopedia article on Hydroxyurea dermopathy
- Wikipedia's article - Hydroxyurea dermopathy
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski